Medicaid is required to cover almost all drugs, but Congress specifically excluded those for weight loss. Even so, 16 states now cover Wegovy. Others are considering it, but it could strain budgets.
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an investigation Wednesday into the “outrageously high prices” of Novo ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage ...
That's because the U.S. Food and Drug ... drugs when prescribed for obesity," KFF said in a news release. How the FDA's change affects Medicare spending will depend in part on how many Part D ...
“It's essential ... an internal medicine specialist who treats patients with Type 2 diabetes and obesity in the Toronto area. Wharton conducts research with several drug companies developing ...
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity ... Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the ...
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity ... Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the ...
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity ... Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the ...
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity ... Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the ...